{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:45:30Z","timestamp":1790685930086,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract\n<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In 2016, the American College of Obstetricians and Gynecologists recommended antenatal corticosteroids in the late preterm period for women at risk for preterm delivery. Limited real-world evidence exists on neonatal outcomes, particularly for twin gestations, following the guideline change. The study objective is to determine the association of antenatal corticosteroids in late preterm singleton and twin pregnancies with respiratory complications and hypoglycemia in a real-world clinical setting.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective cohort study comprising late preterm deliveries (4,341 mother\u2013child pairs) within the Mount Sinai Health System, 2012\u20132018. The exposure of interest is antenatal corticosteroid administration of betamethasone during pregnancy between 34 0\/7 and 36 6\/7\u00a0weeks. Our primary outcomes are neonatal respiratory complications and hypoglycemia. Multivariable logistic regression was used to estimate the association between antenatal corticosteroid exposure and these two outcomes. We stratified the study population by singleton gestations and twins to minimize the potential confounding from different obstetric management between the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among a total of 4,341 mother\u2013child pairs (3,309 <jats:italic>singleton<\/jats:italic> and 1,032 <jats:italic>twin<\/jats:italic> mother\u2013child pairs), 745 mothers received betamethasone, of which 40.94% (305\/745) received the full course. Relative to no treatment, a full course of betamethasone was associated with reduced odds of respiratory complications (OR\u2009=\u20090.53, 95% CI:[0.31\u20130.85], p\u2009&lt;\u20090.01) and increased odds of hypoglycemia (OR\u2009=\u20091.86, 95%CI:[1.34\u20132.56], p\u2009&lt;\u20090.01) in singletons; however, the association with respiratory complications was not significant in twins (OR\u2009=\u20090.42, 95% CI:[0.11\u20131.23], <jats:italic>p<\/jats:italic>\u2009=\u20090.16), but was associated with increased odds of hypoglycemia (OR\u2009=\u20092.18, 95% CI:[1.12\u20134.10], <jats:italic>p<\/jats:italic>\u2009=\u20090.02).<\/jats:p>\n                <jats:p>A partial course of betamethasone (relative to no treatment) was not significantly associated with any of the outcomes, other than respiratory complications in twins (OR\u2009=\u20090.34, 95% CI:[0.12\u20130.82], <jats:italic>p<\/jats:italic>\u2009=\u20090.02).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Exposure to antenatal corticosteroids in singletons and twins is associated with increased odds of hypoglycemia. Among singletons, exposure to the full dosage (i.e. two doses) was associated with decreased odds of respiratory complications but this was only the case for partial dose among twins. Twin gestations were not studied by the Antenatal Late Preterm Steroids trial. Therefore, our study findings will contribute to the paucity of evidence on the benefit of antenatal corticosteroids in this group. Health systems should systematically monitor guideline implementations to improve patient outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-05262-1","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T09:03:47Z","timestamp":1670231027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Late preterm antenatal corticosteroids in singleton and twin gestations: a retrospective cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Luciana A.","family":"Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Han","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina S.","family":"Tsevdos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Kwan","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda B.","family":"Zheutlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan J.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne L.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan M.","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E.","family":"Schadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"issue":"5","key":"5262_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jama.1995.03520290065031","volume":"273","author":"LC Gilstrap","year":"1995","unstructured":"Gilstrap LC, Christensen R, Clewell WH, et al. Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA. 1995;273(5):413\u20138. https:\/\/doi.org\/10.1001\/jama.1995.03520290065031.","journal-title":"JAMA."},{"key":"5262_CR2","doi-asserted-by":"publisher","unstructured":"McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;2021(2). https:\/\/doi.org\/10.1002\/14651858.CD004454.pub4","DOI":"10.1002\/14651858.CD004454.pub4"},{"issue":"14","key":"5262_CR3","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/nejmoa1516783","volume":"374","author":"C Gyamfi-Bannerman","year":"2016","unstructured":"Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 2016;374(14):1311\u201320. https:\/\/doi.org\/10.1056\/nejmoa1516783.","journal-title":"N Engl J Med."},{"key":"5262_CR4","doi-asserted-by":"publisher","unstructured":"4.Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol. 2017;130(2):e102-e109.https:\/\/doi.org\/10.1097\/AOG.0000000000002237","DOI":"10.1097\/AOG.0000000000002237"},{"key":"5262_CR5","doi-asserted-by":"publisher","unstructured":"Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery. Am J Obstet Gynecol. 2016;215(2):B13-B15. https:\/\/doi.org\/10.1016\/j.ajog.2016.03.013","DOI":"10.1016\/j.ajog.2016.03.013"},{"key":"5262_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.07.023","author":"UM Reddy","year":"2021","unstructured":"Reddy UM, Deshmukh U, Dude A, Harper L, Osmundson SS. Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery. Am J Obstet Gynecol. 2021. https:\/\/doi.org\/10.1016\/j.ajog.2021.07.023 (Published online).","journal-title":"Am J Obstet Gynecol."},{"key":"5262_CR7","doi-asserted-by":"publisher","unstructured":"Freret TS, James KE, Melamed A, Gyamfi-Bannerman C, Kaimal AJ, Clapp MA. Late-preterm steroid use among individuals with pregestational diabetes mellitus and with twin gestations. Published onlinehttps:\/\/doi.org\/10.1016\/j.ajog","DOI":"10.1016\/j.ajog"},{"issue":"2","key":"5262_CR8","doi-asserted-by":"publisher","first-page":"280.e1","DOI":"10.1016\/j.ajog.2022.03.037","volume":"227","author":"EOR Kearsey","year":"2022","unstructured":"Kearsey EOR, Been JV, Souter VL, Stock SJ. The impact of the Antenatal Late Preterm Steroids trial on the administration of antenatal corticosteroids. Am J Obstet Gynecol. 2022;227(2):280.e1-280.e15. https:\/\/doi.org\/10.1016\/j.ajog.2022.03.037.","journal-title":"Am J Obstet Gynecol."},{"issue":"11","key":"5262_CR9","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1055\/a-1785-9290","volume":"39","author":"ER McElwee","year":"2022","unstructured":"McElwee ER, Wilkinson K, Crowe R, et al. Indication Creep of Antenatal Late Preterm Steroids. Am J Perinatol. 2022;39(11):1159\u201365. https:\/\/doi.org\/10.1055\/a-1785-9290.","journal-title":"Am J Perinatol."},{"issue":"4","key":"5262_CR10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ajog.2016.06.023","volume":"215","author":"BD Kamath-Rayne","year":"2016","unstructured":"Kamath-Rayne BD, Rozance PJ, Goldenberg RL, Jobe AH. Antenatal corticosteroids beyond 34 weeks gestation: What do we do now? Am J Obstet Gynecol. 2016;215(4):423\u201330. https:\/\/doi.org\/10.1016\/j.ajog.2016.06.023.","journal-title":"Am J Obstet Gynecol."},{"issue":"1","key":"5262_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1067\/mcp.2002.120250","volume":"71","author":"P Ballabh","year":"2002","unstructured":"Ballabh P, Lo ES, Kumari J, et al. Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin Pharmacol Ther. 2002;71(1):39\u201345. https:\/\/doi.org\/10.1067\/mcp.2002.120250.","journal-title":"Clin Pharmacol Ther."},{"issue":"5","key":"5262_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00404-020-05709-w","volume":"302","author":"A Ben-David","year":"2020","unstructured":"Ben-David A, Zlatkin R, Bookstein-Peretz S, Meyer R, Mazaki-Tovi S, Yinon Y. Does antenatal steroids treatment in twin pregnancies prior to late preterm birth reduce neonatal morbidity? Evidence from a retrospective cohort study. Arch Gynecol Obstet. 2020;302(5):1121\u20136. https:\/\/doi.org\/10.1007\/s00404-020-05709-w.","journal-title":"Arch Gynecol Obstet."},{"issue":"2","key":"5262_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00404-019-05191-z","volume":"300","author":"D Martinka","year":"2019","unstructured":"Martinka D, Barrett J, Mei-dan E, Zaltz A, Melamed N. Respiratory morbidity in late preterm twin infants. Arch Gynecol Obstet. 2019;300(2):337\u201345. https:\/\/doi.org\/10.1007\/s00404-019-05191-z.","journal-title":"Arch Gynecol Obstet."},{"key":"5262_CR14","doi-asserted-by":"publisher","unstructured":"Kerstjens JM, Bocca-Tjeertes IF, de Winter AF, Reijneveld SA, Bos AF. Neonatal morbidities and developmental delay in moderately preterm-born children. Pediatrics. 2012;130(2). https:\/\/doi.org\/10.1542\/peds.2012-0079","DOI":"10.1542\/peds.2012-0079"},{"issue":"10","key":"5262_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10654-018-0425-5","volume":"33","author":"R Wickstr\u00f6m","year":"2018","unstructured":"Wickstr\u00f6m R, Ski\u00f6ld B, Petersson G, Stephansson O, Altman M. Moderate neonatal hypoglycemia and adverse neurological development at 2\u20136 years of age. Eur J Epidemiol. 2018;33(10):1011\u201320. https:\/\/doi.org\/10.1007\/s10654-018-0425-5.","journal-title":"Eur J Epidemiol."},{"key":"5262_CR16","doi-asserted-by":"publisher","unstructured":"Goode RH, Rettiganti M, Li J, et al. Developmental outcomes of preterm infants with neonatal hypoglycemia. Pediatrics. 2016;138(6). https:\/\/doi.org\/10.1542\/peds.2016-1424","DOI":"10.1542\/peds.2016-1424"},{"key":"5262_CR17","unstructured":"Martin JA, Hamilton BE, Osterman MJK, Driscoll AK. National Vital Statistics Reports Volume 70, Number 2, March 23 Births: Final Data for 2019; 2019. https:\/\/www.cdc.gov\/nchs\/products\/index.htm. Accessed 30 Nov 2021."},{"key":"5262_CR18","doi-asserted-by":"publisher","unstructured":"Hong S, Lee SM, Kwak DW, et al. Effects of antenatal corticosteroids in twin neonates with late preterm birth (ACTWIN [Antenatal Corticosteroids in TWIN late preterm neonates] trial): Study protocol for a randomized controlled trial. BMC Pregnancy Childbirth. 2019;19(1). https:\/\/doi.org\/10.1186\/s12884-019-2235-5","DOI":"10.1186\/s12884-019-2235-5"},{"key":"5262_CR19","unstructured":"Icahn School of Medicine at Mount Sinai. Mount Sinai Data Warehouse. https:\/\/labs.icahn.mssm.edu\/msdw\/. Accessed 30 Nov 2021."},{"issue":"4","key":"5262_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","volume":"18","author":"SJ Nelson","year":"2011","unstructured":"Nelson SJ, Zeng K, Kilbourne J, Powell T, Moore R. Normalized names for clinical drugs: RxNorm at 6 years. J Am Med Inform Assoc. 2011;18(4):441\u20138. https:\/\/doi.org\/10.1136\/amiajnl-2011-000116.","journal-title":"J Am Med Inform Assoc."},{"key":"5262_CR21","doi-asserted-by":"publisher","unstructured":"Zheutlin AB, Vieira L, Shewcraft RA, et al. Improving postpartum hemorrhage risk prediction using longitudinal electronic medical records. J Am Med Inform Assoc. Published online August 18, 2021. https:\/\/doi.org\/10.1093\/jamia\/ocab161","DOI":"10.1093\/jamia\/ocab161"},{"key":"5262_CR22","doi-asserted-by":"publisher","unstructured":"Li S, Wang Z, Vieira LA, et al. Improving Pre-eclampsia Risk Prediction by Modeling Individualized Pregnancy Trajectories Derived from Routinely Collected Electronic Medical Record Data. https:\/\/doi.org\/10.1101\/2021.03.23.21254178","DOI":"10.1101\/2021.03.23.21254178"},{"key":"5262_CR23","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/. Accessed 30 Nov 2021."},{"key":"5262_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2020.1808614","author":"N \u00dcst\u00fcn","year":"2020","unstructured":"\u00dcst\u00fcn N, Hocao\u011flu M, Turgut A, Arslano\u011flu S, Oval\u0131 F. Does antenatal corticosteroid therapy improve neonatal outcomes in late preterm birth? J Matern-Fetal Neonatal Med. 2020. https:\/\/doi.org\/10.1080\/14767058.2020.1808614 (Published online).","journal-title":"J Matern-Fetal Neonatal Med."},{"key":"5262_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-021-01162-y","author":"O Janssen","year":"2021","unstructured":"Janssen O, Ratner V, Lin J, Fox N, Green R. Respiratory and glycemic control outcomes of late preterm infants after antenatal corticosteroid exposure. J Perinatol. 2021. https:\/\/doi.org\/10.1038\/s41372-021-01162-y (Published online).","journal-title":"J Perinatol."},{"issue":"6","key":"5262_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/tropej\/fmy001","volume":"64","author":"V Ontela","year":"2018","unstructured":"Ontela V, Dorairajan G, Bhat VB, Chinnakali P. Effect of antenatal steroids on respiratory morbidity of late preterm newborns: A randomized controlled trial. J Trop Pediatr. 2018;64(6):531\u20138. https:\/\/doi.org\/10.1093\/tropej\/fmy001.","journal-title":"J Trop Pediatr."},{"key":"5262_CR27","doi-asserted-by":"publisher","unstructured":"Porto AMF, Coutinho IC, Correia JB, Amorim MMR. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: Randomised clinical trial. BMJ. 2011;342(7802). https:\/\/doi.org\/10.1136\/bmj.d1696","DOI":"10.1136\/bmj.d1696"},{"issue":"1","key":"5262_CR28","doi-asserted-by":"publisher","first-page":"100076","DOI":"10.1016\/j.ajogmf.2019.100076","volume":"2","author":"N Badreldin","year":"2020","unstructured":"Badreldin N, Willert GG, Henricks AA, Peaceman A, Caldarelli LA, Yee LM. Implementation of an antenatal late-preterm corticosteroid protocol at a high-volume tertiary care center. Am J Obstet Gynecol MFM. 2020;2(1):100076. https:\/\/doi.org\/10.1016\/j.ajogmf.2019.100076.","journal-title":"Am J Obstet Gynecol MFM."},{"issue":"5","key":"5262_CR29","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/AOG.0b013e31824ea4b2","volume":"119","author":"BD Kamath-Rayne","year":"2012","unstructured":"Kamath-Rayne BD, Defranco EA, Marcotte MP. Antenatal steroids for treatment of fetal lung immaturity after 34 weeks of gestation: An evaluation of neonatal outcomes. Obstet Gynecol. 2012;119(5):909\u201316. https:\/\/doi.org\/10.1097\/AOG.0b013e31824ea4b2.","journal-title":"Obstet Gynecol."},{"issue":"9","key":"5262_CR30","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41372-020-0589-1","volume":"40","author":"KR Uquillas","year":"2020","unstructured":"Uquillas KR, Lee RH, Sardesai S, et al. Neonatal hypoglycemia after initiation of late preterm antenatal corticosteroids. J Perinatol. 2020;40(9):1339\u201348. https:\/\/doi.org\/10.1038\/s41372-020-0589-1.","journal-title":"J Perinatol."},{"issue":"1","key":"5262_CR31","doi-asserted-by":"publisher","first-page":"124S","DOI":"10.1097\/01.AOG.0000533521.16220.7d","volume":"131","author":"MA Alrais","year":"2018","unstructured":"Alrais MA, Chen HY, Sibai BM, Blackwell SC. Frequency of Neonatal Hypoglycemia After Implementation of Antenatal Late Preterm Steroids Use [19K]. Obstet Gynecol. 2018;131(1):124S-124S. https:\/\/doi.org\/10.1097\/01.AOG.0000533521.16220.7d.","journal-title":"Obstet Gynecol."},{"key":"5262_CR32","doi-asserted-by":"publisher","unstructured":"di Pasquo E, Saccone G, Angeli L, et al. Determinants of neonatal hypoglycemia after antenatal administration of corticosteroids (ACS) for lung maturation: Data from two referral centers and review of the literature. Early Hum Dev. 2020;143. https:\/\/doi.org\/10.1016\/j.earlhumdev.2020.104984","DOI":"10.1016\/j.earlhumdev.2020.104984"},{"issue":"3","key":"5262_CR33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/AOG.0000000000002187","volume":"130","author":"SY Salem","year":"2017","unstructured":"Salem SY, Kibel M, Asztalos E, Zaltz A, Barrett J, Melamed N. Neonatal Outcomes of Low-Risk, Late-Preterm Twins Compared with Late-Preterm Singletons. Obstet Gynecol. 2017;130(3):582\u201390. https:\/\/doi.org\/10.1097\/AOG.0000000000002187.","journal-title":"Obstet Gynecol."},{"key":"5262_CR34","doi-asserted-by":"publisher","unstructured":"Kuk JY, An JJ, Cha HH, et al. Optimal time interval between a single course of antenatal corticosteroids and delivery for reduction of respiratory distress syndrome in preterm twins. Am J Obstet Gynecol. 2013;209(3):256.e1-7. https:\/\/doi.org\/10.1016\/j.ajog.2013.06.020.","DOI":"10.1016\/j.ajog.2013.06.020"},{"key":"5262_CR35","doi-asserted-by":"publisher","unstructured":"McElwee ER, Wilkinson K, Crowe R, et al. Latency of late preterm steroid administration to delivery and risk of neonatal hypoglycemia. Am J Obstet Gynecol MFM. 2022;4(5). https:\/\/doi.org\/10.1016\/j.ajogmf.2022.100687","DOI":"10.1016\/j.ajogmf.2022.100687"},{"key":"5262_CR36","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1729561","author":"C Gyamfi-Bannerman","year":"2021","unstructured":"Gyamfi-Bannerman C, Jablonski KA, Blackwell SC, et al. Evaluation of Hypoglycemia in Neonates of Women at Risk for Late Preterm Delivery: An Antenatal Late Preterm Steroids Trial Cohort Study. Am J Perinatol. 2021. https:\/\/doi.org\/10.1055\/s-0041-1729561 (Published online).","journal-title":"Am J Perinatol."},{"key":"5262_CR37","doi-asserted-by":"publisher","unstructured":"Aris IM, Kleinman KP, Belfort MB, Kaimal A, Oken E. A 2017 US reference for singleton birth weight percentiles using obstetric estimates of gestation. Pediatrics. 2019;144(1). https:\/\/doi.org\/10.1542\/peds.2019-0076","DOI":"10.1542\/peds.2019-0076"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05262-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-05262-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05262-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T18:07:14Z","timestamp":1670522834000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-05262-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5262"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-05262-1","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"16 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All research was conducted in accordance with the relevant ethical guidelines and regulations at the Icahn School of Medicine at Mount Sinai.\u00a0The study was approved by the Institutional Review Board at the Icahn School of Medicine at Mount Sinai (IRB-21\u201300824). Informed consent from patient is not required as the study uses de-identified data under the HIPAA privacy rule.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"904"}}